WallStreetZenWallStreetZen

NYSE: SYK
Stryker Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SYK

Based on 17 analysts offering 12 month price targets for Stryker Corp

Min Forecast
$298.00+5.45%
Avg Forecast
$367.71+30.12%
Max Forecast
$420.00+48.62%

Should I buy or sell SYK stock?

Based on 18 analysts offering ratings for Stryker Corp.

Strong Buy
Strong Buy
10 analysts 55.56%
Buy
5 analysts 27.78%
Hold
3 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although SYK's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates SYK as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their SYK stock forecasts and price targets.

SYK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-12
lockedlocked$00.00+00.00%2026-10-07
lockedlocked$00.00+00.00%2026-10-07
lockedlocked$00.00+00.00%2026-09-30
lockedlocked$00.00+00.00%2026-09-22
Canaccord Genuity
Top 16%
85
Strong BuyMaintains$385.00+36.23%2026-09-18
Citigroup
Top 9%
92
Strong BuyMaintains$360.00+27.39%2026-09-10
Wells Fargo
Top 14%
87
Strong BuyMaintains$348.00+23.14%2026-09-09
Wolfe Research
Top 25%
76
HoldDowngradesN/AN/A2026-08-13
Citizens
Bottom 3%
3
BuyMaintains$400.00+41.54%2026-08-03

1 of 2

Forecast return on equity

Is SYK forecast to generate an efficient return?

Company
33.18%
Industry
22.06%
Market
168.79%
SYK's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SYK forecast to generate an efficient return on assets?

Company
16.6%
Industry
13.76%
SYK is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SYK earnings per share forecast

What is SYK's earnings per share in the next 3 years based on estimates from 31 analysts?

Avg 1 year Forecast
$15.14+55.42%
Avg 2 year Forecast
$16.87+73.18%
Avg 3 year Forecast
$18.75+92.48%
SYK's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SYK revenue forecast

What is SYK's revenue in the next 3 years based on estimates from 30 analysts?

Avg 1 year Forecast
$27.6B+6.63%
Avg 2 year Forecast
$29.9B+15.89%
Avg 3 year Forecast
$32.3B+24.9%
SYK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SYK earnings growth forecast

How is SYK forecast to perform vs Medical Devices companies and vs the US market?

Company
24.33%
Industry
21.97%
Market
32.22%
SYK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SYK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SYK's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SYK revenue growth forecast

How is SYK forecast to perform vs Medical Devices companies and vs the US market?

Company
7.71%
Industry
7.24%
Market
14.03%
SYK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SYK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SYK vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SYK$282.60$367.71+30.12%Strong Buy
MDT$91.93$103.59+12.68%Buy
BSX$43.84$65.24+48.81%Strong Buy
EW$86.39$102.87+19.07%Strong Buy
ABT$101.82$122.50+20.31%Strong Buy
View Top Medical Device Stocks

Stryker Stock Forecast FAQ

Is Stryker Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 18 Wall Street analysts covering (NYSE: SYK) stock is to Strong Buy SYK stock.

Out of 18 analysts, 10 (55.56%) are recommending SYK as a Strong Buy, 5 (27.78%) are recommending SYK as a Buy, 3 (16.67%) are recommending SYK as a Hold, 0 (0%) are recommending SYK as a Sell, and 0 (0%) are recommending SYK as a Strong Sell.

If you're new to stock investing, here's how to buy Stryker stock.

What is SYK's earnings growth forecast for 2026-2028?

(NYSE: SYK) Stryker's forecast annual earnings growth rate of 24.33% is forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 21.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.22%.

Stryker's earnings in 2026 is $3,729,000,000.On average, 31 Wall Street analysts forecast SYK's earnings for 2026 to be $5,806,413,698, with the lowest SYK earnings forecast at $5,600,933,618, and the highest SYK earnings forecast at $6,069,468,093. On average, 31 Wall Street analysts forecast SYK's earnings for 2027 to be $6,470,186,855, with the lowest SYK earnings forecast at $6,036,979,456, and the highest SYK earnings forecast at $6,878,999,007.

In 2028, SYK is forecast to generate $7,191,035,680 in earnings, with the lowest earnings forecast at $6,412,881,041 and the highest earnings forecast at $7,640,199,717.

What is SYK's revenue growth forecast for 2026-2028?

(NYSE: SYK) Stryker's forecast annual revenue growth rate of 7.71% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.03%.

Stryker's revenue in 2026 is $25,837,000,000.On average, 30 Wall Street analysts forecast SYK's revenue for 2026 to be $10,567,437,417,300, with the lowest SYK revenue forecast at $10,187,700,101,760, and the highest SYK revenue forecast at $11,018,902,892,442. On average, 30 Wall Street analysts forecast SYK's revenue for 2027 to be $11,485,327,716,378, with the lowest SYK revenue forecast at $10,997,806,374,912, and the highest SYK revenue forecast at $12,823,230,500,826.

In 2028, SYK is forecast to generate $12,377,902,194,420 in revenue, with the lowest revenue forecast at $11,766,870,332,142 and the highest revenue forecast at $13,077,923,003,370.

What is SYK's forecast return on assets (ROA) for 2026-2029?

(NYSE: SYK) forecast ROA is 16.6%, which is higher than the forecast US Medical Devices industry average of 13.76%.

What is SYK's Price Target?

According to 17 Wall Street analysts that have issued a 1 year SYK price target, the average SYK price target is $367.71, with the highest SYK stock price forecast at $420.00 and the lowest SYK stock price forecast at $298.00.

On average, Wall Street analysts predict that Stryker's share price could reach $367.71 by Oct 12, 2027. The average Stryker stock price prediction forecasts a potential upside of 30.12% from the current SYK share price of $282.60.

What is SYK's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: SYK) Stryker's current Earnings Per Share (EPS) is $9.74. On average, analysts forecast that SYK's EPS will be $15.14 for 2026, with the lowest EPS forecast at $14.60, and the highest EPS forecast at $15.82. On average, analysts forecast that SYK's EPS will be $16.87 for 2027, with the lowest EPS forecast at $15.74, and the highest EPS forecast at $17.93. In 2028, SYK's EPS is forecast to hit $18.75 (min: $16.72, max: $19.92).

What is SYK's forecast return on equity (ROE) for 2026-2029?

(NYSE: SYK) forecast ROE is 33.18%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.